Trademarkia Logo

Australia

AU$
OCVIMOY
Accepted: In opposition period

Last updated on 18 Apr 2025

Owner Info

Alkeus Pharmaceuticals, Inc.

44 Brattle Street, 2nd Floor

Cambridge MA 02138, UNITED STATES OF AMERICA

Serial Number

2538621 filed on 10 Mar 2025

Correspondent

Keith Barritt Fish & Richardson P.C.

P.O. Box 1022,

Minneapolis MN 55440-1022,

UNITED STATES OF AMERICA

OCVIMOY

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of eye disease.

Mark Details


Serial Number

2538621

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

3 Oct 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
18th Apr 2025Application Accepted correspondence sent
17th Apr 2025IP Right has been Examined
17th Apr 2025IP Right Acceptance Published
17th Apr 2025Status change to Accepted
10th Apr 2025Examination expedited
10th Apr 2025Awaiting examination
10th Apr 2025IP Right Filed Published
10th Apr 2025Status change to Published
10th Apr 2025Status change to Filed
10th Apr 2025Application Received